Amprion

Amprion is a biotechnology company based in San Francisco, California, established in 2007. The firm specializes in the diagnosis of neurodegenerative diseases, particularly focusing on conditions such as Parkinson’s disease, Alzheimer’s disease, and Lewy Body Dementia. Amprion develops innovative early detection technologies aimed at improving understanding of brain health. By leveraging personal biometrics and collective knowledge, the company seeks to enhance the ability of researchers and healthcare professionals to identify and understand these brain diseases, ultimately contributing to better patient outcomes and advancing the field of neuroscience.